Ertapenem+meropenem including double carbapenem therapy (EMDCT) versus meropenem+imipenem including double carbapenem therapy (MIDCT) in the therapy of carbapenem-resistant Klebsiella pneumoniae infections (CRKPI): A retrospective matched cohort stud

Ertapenem+meropenem including double carbapenem therapy (EMDCT) versus meropenem+imipenem including double carbapenem therapy (MIDCT) in the therapy of carbapenem-resistant Klebsiella pneumoniae infections (CRKPI): A retrospective matched cohort stud

BACKGROUND-AIM: In this retrospective matched cohort study, we aimed to compare the clinical outcomes of EMDCT including therapy receiving cases with MIDCT receiving CRKPI cases. MATERIALS/METHODS: This study was performed at a 1800+ bedded tertiary-care hospital.Adult patients with culture proven C...

Full description

Saved in:
Bibliographic Details
Main Authors: Merve Mert Vahabi, Deniz Akyol, Deniz Dağ, Gamze Şanlıdağ, Şevket Yeniyol, Arda Kaya, Dilşah Başkol, Seichan Ketentzi, Buğra Özkara, Şükrü Dirik, Gökhan Vatansever, Derya Kaya, Meltem Tüğdür, Hüseyin Aytaç Erdem, Feriha Çilli, Hilal Sipahi, Hüsnü Pullukçu, Meltem Taşbakan, Bilgin Arda, Oğuz Reşat Sipahi
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Klebsiella pneumoniae
carbapenem resistance
multidrug resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524001863
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524001863

Similar Items